Article Details
Retrieved on: 2024-10-17 17:37:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Adicet Bio's ADI-100, an investigational allogeneic chimeric antigen receptor (CAR)-engineered gamma delta T-cell therapy currently being ...
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here